What is it about?
Inflammation is seen as a driver for Alzheimer's Disease. In this study we identified that novel markers of inflammation, such as Adenosine Deaminase, which is responsible for sleep regulation, are predictive of the likelihood of Alzheimer's in a clinical population.
Photo by Milad Fakurian on Unsplash
Why is it important?
Our study found increased levels of specific markers of inflammation in Alzheimer's Disease. These markers may in future help identify which patients are at most risk of progression to Alzheimer's. Further validation is required to assess the prognostic efficacy of these inflammation markers when used in conjunction with established measures of Alzheimer's Disease.
Read the Original
This page is a summary of: Biomarkers of Inflammation Increase with Tau and Neurodegeneration but not with Amyloid-β in a Heterogenous Clinical Cohort, Journal of Alzheimer s Disease, October 2022, IOS Press, DOI: 10.3233/jad-220523.
You can read the full text:
The following have contributed to this page